Valeant expected to announce Herendeen as new CFO: WSJ
CALIFORNIA – Valeant Pharmaceuticals International Inc is expected to announce it has hired Paul Herendeen of Zoetis Inc as its new chief financial officer, according to a Wall Street Journal report citing sources close to the companies.
Herendeen would replace Robert Rosiello, who will remain with the Canadian pharmaceutical company as head of corporate development and strategy, according to the report.
The hire, expected to be announced on Monday, is part of a continued shake-up at the drugmaker, the WSJ added. -Reuters